NRSN   $6.18  -7.82% Market Open

NeuroSense Therapeutics Ltd.

EMA (20): 2026-09-08 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2026-06-22 the price crossed down the moving average line and demonstrates a downside trend.

EMA (100): 2026-05-29 the price crossed down the moving average line and demonstrates a strong downside trend.

RSI: RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it crossed the signal line from the top and falls. These factors mean that the market confirms the tendency to fall. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

Trend Type linear down
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -19.83%
EMA (20) date of signal Sept. 8, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -57.52%
EMA (50) date of signal June 22, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -59.19%
EMA (100) date of signal May 29, 2026, 3 a.m.
RSI Signals bearish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Sept. 11, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -16.41%
MACD date of signal Sept. 9, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield 0.96%
Stochastic date of signal Sept. 10, 2026, 3 a.m.
Updated Sept. 12, 2026, 11:02 p.m.